Small, smart and powerful – Anton Paar's MCP 150 polarimeter impresses with its sophisticated features
Anton Paar`s compact MCP 150 polarimeter is a one-size-fits-all solution: Although it is compact, it provides full 21 CFR Part 11 compliance, including electronic signature requirements. The easy-to-use touchscreen supports fast navigation with unmatched simplicity. Multiple measurement capabilities and customized methods make both, routine and unique measurements better than ever. This model is equipped with an enhanced accuracy (± 0.005 °OR), for extremely high precision measurement. The powerful Peltier temperature control guarantees fast and even temperature distribution of the sample within the range of 15 °C to 35 °C. With the intelligent Toolmaster™ technology, information on all relevant parameters is wirelessly transferred to the instrument. This eliminates user errors and ensures that every change is recorded in the Audit Trail. LIMS and FTP connectivity are fully supported.
For more information on MCP 150 and other Anton Paar solutions, visit www.anton-paar.com.
Anton Paar GmbH was established in 1922 as a one-man locksmith’s workshop. Today, over 2,000 employees worldwide develop, produce and distribute high-quality measuring instruments for the determination of properties such as density, temperature and viscosity as well as high-precision mechanical parts and assemblies. Anton Paar has strong links with universities and research laboratories worldwide. The company is owned by the Santner Foundation, which invests in research in the field of science and technology as well as in the rehabilitation of drug addicts.
www.anton-paar.cominfo@anton-paar.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
